Flow cytometry analysis showed that around 3–7% of tumor cells expressed CXCR4 (α6-integrin+/CXCR4+ cells) in WD-SCCs, and this frequency was significantly increased in PD/S-SCCs (Fig. 1e, f). Here, CXCR4 is linked to neoplasm.